Ginseng reduces the micronuclei yield in lymphocytes after irradiation

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 557, Issue 1, 2004, Pages 75-84

  Lee, Tung Kwang ^a   Allison, Ron R ^a   O'Brien, Kevin F ^b   Khazanie, Prabhaker G ^a   Johnke, Roberta M ^a   Brown, Randy ^a   Bloch, Richard M ^a   Tate, Matthew L ^a   Dobbs, Larry J ^a   Kragel, Peter J ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Ginseng; Lymphocytes; Micronuclei; Radioprotection

Indexed keywords

CESIUM 137; GINSENG EXTRACT; RADIOPROTECTIVE AGENT;

ADULT; ARTICLE; BIOASSAY; CELL CYCLE G0 PHASE; CELL PROLIFERATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOGENETICS; DATA ANALYSIS; HUMAN; HUMAN CELL; IRRADIATION; LYMPHOCYTE; MALE; MICRONUCLEUS; MONONUCLEAR CELL; NORMAL HUMAN; POISSON DISTRIBUTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION;

PANAX GINSENG;

EID: 9144226879     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2003.10.002     Document Type: Article

References (37)

1. Ong Y.C., Yong E.L. Panax (Ginseng) - panacea or placebo? Molecular and cellular basis of its pharmacological activity. Ann. Acad. Med. 29:2000;42-46.
2. R Shin H., Kim J.Y., Yun T.K., Morgan G., Vainio H. The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control. 11:2000;565-576.
3. Vogler B.K., Pittler M.H., Ernst E. The efficacy of ginseng. A systemic review of randomized clinical trials. Eur. J. Clin. Pharmacol. 55:1999;567-575.
4. Kitts D.D., Wijewickreme A.N., Hu C. Antioxidant properties of a North American ginseng extract. Mol. Cell. Biochem. 203:2000;1-10.
5. 3H -thymidine integration of human blood lymphocytes Chin. Med. J. 104:1991;399-401.
6. Kim J.Y., Germolec D.R., Luster M.I. Panax ginseng as a potential immunomodulator: studies in mice. Immunopharmacol. Immunotoxicol. 12:1990;257-276.
7. Kim S.H., Cho C.K., Yoo S.Y., Koh K.H., Yun H.G., Kim T.H. In vivo radioprotective activity of Panax Ginseng and diethyldithlocarbamate. In Vivo. 7:1993;467-470.
8. 2 in human blood lymphocytes. Cancer Res. 55:1995;1221-1223.
9. Chan T.W.D., But P.P.H., Cheng S.W., Kwok I.M.Y., Lau F.W., Xu H.X. Differentiation and authentication of Panax ginseng, Panax quinquefolius, and Ginseng products by using HPLC/MS. Anal. Chem. 72:2000;1281-1287.
10. 3 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotion. Mutat. Res. 523:2003;75-85.
11. Attele A.S., Wu J.A., Yuan C.-S. Ginseng pharmacology. Biochem. Pharmacol. 58:1999;1685-1693.
12. Liu W.K., Xu S.X., Che C.T. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci. 67:2000;1297-1306.
13. Ben-Hur E., Fulder S. Effect of Panax ginseng saponins and Eleutherococcus senticosus on survival of cultured mammalian cells after ionizing radiation. Am. J. Chin. Med. 9:1981;48-56.
14. Liu J., Wang S., Liu H., Yang L., Nan G. Stimulatory effect of saponin from panax ginseng on immune function of lymphocytes in the elderly. Mech. Ageing Dev. 83:1995;43-53.
15. 1 of Panax Ginseng on mitosis in human blood lymphocytes in vitro. Am. J. Chin. Med. 8:1980;254-267.
16. Duda R.B., Zhong Y., Navas V., Li M.Z.C., Toy B.R., Alavarez J.G. American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J. Surg. Oncol. 72:1999;230-239.
17. Kim T.-H., Lee Y.-S., Cho C.-K., Park S., Choi S.-Y., Yool S.-Y. Protective effect of ginseng on radiation-induced DNA double strand breaks and reapir in murine lymphocytes. Cancer Biother. Radiopharm. 11:1996;267-272.
18. kip1. Cancer Lett. 110:1996;193-200.
19. Chen F.D., Wu M.C., Wang H.E., Hwang J.J., Hong C.Y., Huang Y.T., Yen S.H., Ou Y.H. Sensitization of a tumor, but not normal tissue, to the cytotoxic effect of ionizing radiation using panax notoginseng extract. Am. J. Chin. Med. 29:2001;517-524.
20. Lee B.M., Lee S.K., Kim H.S. Inhibition of oxidative DNA damage, 8-OhdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, beta-carotene and red ginseng. Cancer Lett. 132:1998;219-227.
21. Song J.-Y., Han S.-K., Bae K.-G., Lim D.-S., Son S.-J., Jung I.-S., Yi S.-Y., Yun Y.-S. Radioprotective effects of ginsan, an immunomodulator. Radiat. Res. 159:2003;768-774.
22. Zhang J.-S., Sigdestad C.P., Gemmell M.A., Grdina D.J. Modification of radiation response in mice by fractionated extracts of Panax ginseng. Radiat. Res. 112:1987;156-163.
23. Littlefield L.G., Joiner E.E., Colyer S.P., Sallam F., Frome E.L. Concentration-dependent protection against X-ray-induced chromosome aberrations in human lymphocytes by the aminothiol WR-1065. Radiat. Res. 133:1993;88-93.
24. 3H -TdR integration of human blood lymphocyte Chin. Med. J. 104:1991;399-401.
25. Bonassi M. Fenech S., Turner J., Lando C., Ceppi M., Chang W.P., Holland N., Kirsch-Volders M.et al. Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN project. Mutat. Res. 534:2003;45-64.
26. Fenech M., Morley A.A. Measurement of micronuclei in lymphocytes. Mutat. Res. 147:1985;29-36.
27. Catena C., Conti D., Parasacchi P., Mareno P., Bortolato B. Micronuclei in cytokinesis-blocked lymphocytes may predict patient response to radiotherapy. Int. J. Radiat. Biol. 70:1996;301-308.
28. Floyd D.N., Cassoni A.M. Intrinsic radiosensitivity of adult and cord blood lymphocytes as determined by the micronucleous assay. Eur. J. Cancer. 30A:1994;615-620.
29. Lee T.K., Wiley A.L. Jr., Esinhart J.D., Blackburn L.D. Radiation dose-rependent variations of micronuclei production in cytochalasin B-blocked human lymphocytes. Teratog. Carcinog. Mutagen. 14:1994;1-12.
30. SPSS Base 10.0 Application Guide, 2001 SPSS Inc., Chicago, IL.
31. Ekstrand K.E., Dixon L.D. Lymphocytes chromosome aberrations in partial-body fractionated radiation therapy. Phys. Med. Biol. 27:1982;407-411.
32. Thierens H., Vral A., Van Eijkeren M., Spelman F., de Riddle L. Micronucleous induction in peripheral blood lymphocytes of patients under radiotherapy treatment for cervical cancer or Hodgkin's disease. Int. J. Radiat. Biol. 67:1995;529-539.
33. Clark L.S., Albertini R.J., Nicklas J.A. Hprt mutations in human T-lymphocytes reflect radioprotective effects of the aminothiol, WR-1065. Carcinogenesis. 17:1996;2647-2653.
34. Lee T.K., Wiley A.L., Means J.A., Esinhart J.D., Blackburn L.D. Frequencies of micronuclei in human lymphocytes: comparison between healthy donors and cancer patients and their in vitro response to ionizing radiation. Radiat. Oncol. Invest. 1:1993;148-152.
35. Moulder J.E. Report on an interagency workshop on the radiobiology of nuclear terrorism. Molecular and cellular biology of moderate dose (1-10 Sv) radiation and potential mechanisms of radiation protection (Bethesda, Maryland, December 17-18, 2001). Radiat. Res. 158:2002;118-124.
36. 0 human lymphocytes. Environm. Mol. Mutagen. 37:2001;117-127.
37. Kligerman M.M., Glover D.J., Turrisi A.T. Toxicity of WR-2721 administration in single and multiple doses. Int. J. Radiat. Oncol. Biol. Phys. 10:1984;1773-1776.